[ Price : $8.95]
Members of the FDA Peripheral and Central Nervous System Drugs Advisory Committee vote 15-2 that lack of efficacy in a BioMarin Ph...[ Price : $8.95]
Pfizer says that a Phase 3 trial of its Lyrica to treat adults with chronic post-traumatic peripheral neuropathic pain did not mee...[ Price : $8.95]
FDA clears an EDDA Technology 510(k) for the IQQA Guide system, a device that supports intra-operative precision 3D navigation for...[ Price : $8.95]
Federal Register Notice: FDA determines that Tylenol with Codeine in different strengths was not withdrawn from sale for reasons o...[ Price : $8.95]
Federal Register Notice: FDA plans a public meeting 3/17/16 on Patient-Focused Drug Development for Psoriasis.[ Price : $8.95]
A Goodwin Procter post says there are three cases pending in federal courts that will shed further light on Biologics Price Compet...[ Price : $8.95]
FDA clears a Theralase Technologies 510(k) for its next generation therapeutic laser, the TLC-2000 Therapeutic Medical Laser Syste...[ Price : $8.95]
FDA grants Cellceutix a Fast Track Designation for Brilacidin-OM, an oral rinse formulation of the companys defensin-mimetic Brila...